跳到正文
原文
监管与产业动态· FierceBiotech·· 2 天前评分39

MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ - Fierce Biotech

MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ - Fierce Biotech

来源:监管与产业动态 · news.google.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org